Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Blood

• Publication date

  2010-07-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2009-12-257345PMID 20339089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Redox Regulation of Multidrug Resistance in Cancer Chemotherapy: Molecular Mechanisms and Therapeutic Opportunities

  2009cited by this paper
• B and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK

  2009cited by this paper
• TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

  2009cited by this paper
• The biology of Hodgkin's lymphoma

  2009cited by this paper
• Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival.

  2009cited by this paper
• From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 27, 2013. For personal use

  2008cited by this paper
• Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis

  2008cited by this paper
• Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs.

  2008cited by this paper
• Overexpressed NF-kappaB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells.

  2008cited by this paper
• Topoisomerase IIα Expression as an Independent Prognostic Factor in Hodgkin's Lymphoma

  2008cited by this paper
• Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin’s lymphoma by array-based comparative genomic hybridization

  2008cited by this paper
• PKCη expression contributes to the resistance of hodgkin's lymphoma cell lines to apoptosis

  2007cited by this paper
• Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells

  2007cited by this paper
• Resolving the resolution of array CGH.

  2007cited by this paper
• A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines.

  2007cited by this paper
• Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications.

  2007cited by this paper
• HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.

  2007cited by this paper
• Comprehensive Analysis of Copy Number and Allele Status Identifies Multiple Chromosome Defects Underlying Follicular Lymphoma Pathogenesis

  2007cited by this paper
• Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: A combined comparative genomic hybridization and microsatellite analysis

  2006cited by this paper
• Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.

  2006cited by this paper
• Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma.

  2006cited by this paper
• High-resolution array CGH increases heterogeneity tolerance in the analysis of clinical samples.

  2005cited by this paper
• A multiplex PCR predictor for aCGH success of FFPE samples

  2005cited by this paper
• Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group.

  2005cited by this paper
• Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells

  2005cited by this paper
• Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.

  2005cited by this paper
• Signaling to NF-kappaB.

  2004cited by this paper
• Microarray-based Detection of Multidrug Resistance in Human Tumor Cells by Expression Profiling of ATP-binding Cassette Transporter Genes

  2004cited by this paper
• A tiling resolution DNA microarray with complete coverage of the human genome

  2004cited by this paper
• Cytogenetic and comparative genomic hybridization findings in four cases of breast cancer after neoadjuvant chemotherapy.

  2003cited by this paper
• Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.

  2003cited by this paper
• Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

  2003cited by this paper
• Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma.

  2003cited by this paper
• Classical Hodgkin lymphoma is associated with frequent gains of 17q

  2003cited by this paper
• Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2

  2003cited by this paper
• Transcriptional analysis of the B cell germinal center reaction

  2003cited by this paper
• Long-term cause-specific mortality of patients treated for Hodgkin's disease.

  2003cited by this paper
• Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

  2002cited by this paper
• Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.

  2002cited by this paper
• Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.

  2002cited by this paper
• Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.

  1999cited by this paper
• Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells.

  1999cited by this paper
• Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα

  1999cited by this paper
• A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

  1998cited by this paper
• Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease.

  1997cited by this paper
• CD95 (Fas/Apo-1)-induced apoptosis results in loss of glucose transporter function.

  1996cited by this paper
• Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development.

  1994cited by this paper
• CD40 expression in Hodgkin's disease.

  1994cited by this paper

• Aberrant Expression and Oncogenic Activity of SPP1 in Hodgkin Lymphoma

  2025cites this paper
• Molecular profiling of cell-free DNA from classic Hodgkin lymphoma patients identifies potential prognostic clusters and corresponds with disease dynamics

  2025cites this paper
• B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas.

  2025cites this paper
• The art of war: using genetic insights to understand and harness radiation sensitivity in hematologic malignancies

  2025cites this paper
• The BTLA–HVEM axis restricts CAR T cell efficacy in cancer

  2024cites this paper
• Molecular biomarkers in classic Hodgkin lymphoma.

  2024cites this paper
• Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers

  2024cites this paper
• The biology of classical Hodgkin lymphoma.

  2024cites this paper
• Advances in Hodgkin lymphoma research.

  2024cites this paper
• Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma

  2024cites this paper
• Nodular lymphocyte-predominant Hodgkin lymphoma: advances in disease biology, risk stratification, and treatment

  2024cites this paper
• Overexpression of MRP1/ABCC1, Survivin and BCRP/ABCC2 Predicts the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Treatment

  2023cites this paper
• Predictive and prognostic molecular biomarkers in lymphomas.

  2023cites this paper
• Hodgkin lymphoma: Focus on evolving treatment paradigms.

  2023cites this paper
• Potential Associations between Vascular Biology and Hodgkin’s Lymphoma: An Overview

  2023cites this paper
• Classical Hodgkin Lymphoma: Tumor Structure and Prognostic Value of the Immune Microenvironment

  2023cites this paper
• A genetic profiling guideline to support diagnosis and clinical management of lymphomas

  2023cites this paper
• Classic Hodgkin lymphoma in young people.

  2023cites this paper
• Diagnostic Utility of STAT6 and pSTAT6 Immunohistochemistry for Distinguishing Classic Hodgkin Lymphoma and Peripheral T-Cell Lymphoma With Hodgkin and Reed-Sternberg–like Cells

  2023cites this paper
• Identification and Interpretation of eQTL and eGenes for Hodgkin Lymphoma Susceptibility

  2023influential citation
• Genetic lesions and targeted therapy in Hodgkin lymphoma

  2023cites this paper
• Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population

  2022cites this paper
• An update on molecular features and therapeutic perspectives of pediatric classical Hodgkin Lymphoma. What the clinician needs to know?

  2022cites this paper
• Germline HOXB13 mutation p.G84E do not confer an increased bladder or kidney cancer risk in polish population

  2022cites this paper
• Identification of prognostic factors in classic Hodgkin lymphoma by integrating whole slide imaging and next generation sequencing.

  2022cites this paper
• Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma

  2022cites this paper
• A t(11;14)(q13;q32)/CCND1::IGH carrying progenitor germinal B-cell with subsequent cytogenetic aberrations contributes to the development of classic Hodgkin lymphoma.

  2022cites this paper
• NF-κB Mutations in Germinal Center B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells

  2022cites this paper
• Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma

  2022cites this paper
• An Update on the Pathology and Molecular Features of Hodgkin Lymphoma

  2022cites this paper
• Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial.

  2021cites this paper
• Mixed cellularity Hodgkin lymphoma

  2021cites this paper
• Genomic studies of Hodgkin lymphoma using circulating cell-free DNA

  2021cites this paper
• Aggressive Mediastinal Lymphomas.

  2021cites this paper
• Classic Hodgkin Lymphoma - Old Disease, New Directions: An Update on Pathology, Molecular Features and Biological Prognostic Markers.

  2021cites this paper
• The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA.

  2021cites this paper
• Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma

  2021cites this paper
• Molecular biology of Hodgkin lymphoma

  2021cites this paper
• Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma.

  2020cites this paper
• A 2020 Vision Into Hodgkin Lymphoma Biology

  2020cites this paper
• Hodgkin lymphoma

  2020cites this paper
• Biological Difference Between Epstein–Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact

  2020cites this paper
• ABC-transporters and drug efflux in hematologic cancers

  2020cites this paper
• Pathology and Molecular Pathology of Hodgkin Lymphoma

  2020cites this paper
• Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms

  2019cites this paper
• Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA

  2019cites this paper
• Origin and Pathogenesis of B Cell Lymphomas.

  2019cites this paper
• The Unsolved Puzzle of c-Rel in B Cell Lymphoma

  2019cites this paper
• The Immune Landscape and Response to Immune Checkpoint Blockade Therapy in Lymphoma.

  2019cites this paper
• Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma.

  2019cites this paper
• Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

  2019cites this paper
• Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion.

  2019cites this paper
• Hodgkin Lymphoma, Classical

  2019cites this paper
• Implications of the tumor immune microenvironment for staging and therapeutics

  2018cites this paper
• Pathogenesis and Molecular Genetics of Hodgkin Lymphoma

  2018cites this paper
• Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome

  2018cites this paper
• Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma

  2018cites this paper
• Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives

  2018cites this paper
• Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues

  2018cites this paper
• Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma

  2018cites this paper
• Novel Biomarker Approaches in Classic Hodgkin Lymphoma

  2018cites this paper
• Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies

  2018cites this paper
• Diagnosis of Hodgkin lymphoma in the modern era

  2018cites this paper
• The translational science of hodgkin lymphoma

  2018cites this paper
• PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.

  2018cites this paper
• Combined linkage and association analysis of classical Hodgkin lymphoma

  2018cites this paper
• Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.

  2018cites this paper
• Genetics of classical Hodgkin Lymphoma

  2018cites this paper
• Mixed cellularity classical Hodgkin lymphoma (MCcHL)

  2018cites this paper
• Classical Hodgkin lymphoma

  2018cites this paper
• The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas

  2018cites this paper
• Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.

  2017cites this paper
• Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma.

  2017cites this paper
• Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.

  2017cites this paper
• Clinical Implications of inter-tumour, intra-tumour, and tumour microenvironment heterogeneity in B-cell lymphomas

  2017cites this paper
• The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis

  2017cites this paper
• Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma.

  2017cites this paper
• 1 Recent Insights into the Biology of Hodgkin ' s Lymphoma

  2017cites this paper
• The genetics of Hodgkin lymphoma: an overview and clinical implications

  2017cites this paper
• [Immune-checkpoint and hemopathies].

  2017cites this paper
• Exploring in vivo consequences of c-Rel overexpression in terminal B cell differentiation

  2016cites this paper
• The 2008 WHO Classification of B-Cell Lymphomas by the Pathologist’s Clinical Point of View

  2016cites this paper
• Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma

  2016influential citation
• NF-κB deregulation in Hodgkin lymphoma.

  2016cites this paper
• Karyotypic abnormalities associated with Epstein-Barr virus status in classical Hodgkin lymphoma.

  2016cites this paper
• Genetic background of relapsing lymphoid neoplasms : comprehensive genetic characterization of primary - relapse pairs by chromosomal copy number and mutational analysis

  2016cites this paper
• WNT signalling affects cell migration, invasion and the lymphoma-endothelial interplay in Hodgkin Lymphoma

  2016cites this paper
• Hodgkin lymphoma: Pathology and biology.

  2016cites this paper
• PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.

  2016cites this paper
• Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma

  2016cites this paper
• EBV‐Positive and EBV‐Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features

  2016cites this paper
• Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.

  2015cites this paper
• Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma

  2015cites this paper
• Diagnostic Utility of the Germinal Center–associated Markers GCET1, HGAL, and LMO2 in Hematolymphoid Neoplasms

  2015cites this paper
• Unexpected functions of nuclear factor-&kgr;B during germinal center B-cell development: implications for lymphomagenesis

  2015cites this paper
• Regulatory B cells in anti-tumor immunity.

  2015cites this paper
• Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.

  2015cites this paper
• Establishment of stable MRP1 knockdown by lentivirus-delivered shRNA in the mouse testis Sertoli TM4 cell line

  2015influential citation
• Lymphocyte-Rich Classical Hodgkin Lymphoma. A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma.

  2015cites this paper
• Hodgkin lymphoma and its cellular microenvironment

  2015cites this paper